Clinical Trial Update: Bucillamine Phase 2 Trial in Patients With Cystinuria [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating bucillamine for cystinuria. The sponsor is Revive Therapeutics, Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystinuria

Drugs mentioned

• Bucillamine (bucillamine)

Snippet

Sponsor: Revive Therapeutics, Ltd. | Conditions: Cystinuria | Phase 2 | Status: UNKNOWN